The global market for ivermectin in veterinary use refers to the industry that produces and supplies the antiparasitic drug, ivermectin, for veterinary applications. Ivermectin is a broad-spectrum anthelmintic medication used to treat and prevent various parasitic infestations in animals.
The global Ivermectin in Veterinary Use market is projected to grow from US$ 52 million in 2024 to US$ 64 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period.
The global ivermectin in veterinary use market plays a significant role in addressing parasitic infestations and promoting animal health in various species. The market continues to grow as the need for effective parasite control measures remains prevalent, and the focus on preventive healthcare in animals continues to increase.
In terms of production side, this report researches the Ivermectin in Veterinary Use production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Ivermectin in Veterinary Use by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Ivermectin in Veterinary Use, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Ivermectin in Veterinary Use, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Ivermectin in Veterinary Use, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ivermectin in Veterinary Use sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Ivermectin in Veterinary Use market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Ivermectin in Veterinary Use sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Merck
Bayview Pharmacy
Athens Life Sciences
Geevet Remedies
Sriwalls Health Care
Segment by Type
Oral
Injection
Segment by Application
Cattle
Sheep
Swine
Horse
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Ivermectin in Veterinary Use production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Ivermectin in Veterinary Use in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Ivermectin in Veterinary Use manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ivermectin in Veterinary Use sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Ivermectin in Veterinary Use Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Ivermectin in Veterinary Use 麻豆原创 Size by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.3 麻豆原创 by Application
1.3.1 Global Ivermectin in Veterinary Use 麻豆原创 Size by Application, 2019 VS 2023 VS 2030
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Swine
1.3.5 Horse
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Ivermectin in Veterinary Use Production
2.1 Global Ivermectin in Veterinary Use Production Capacity (2019-2030)
2.2 Global Ivermectin in Veterinary Use Production by Region: 2019 VS 2023 VS 2030
2.3 Global Ivermectin in Veterinary Use Production by Region
2.3.1 Global Ivermectin in Veterinary Use Historic Production by Region (2019-2024)
2.3.2 Global Ivermectin in Veterinary Use Forecasted Production by Region (2025-2030)
2.3.3 Global Ivermectin in Veterinary Use Production 麻豆原创 Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Ivermectin in Veterinary Use Revenue Estimates and Forecasts 2019-2030
3.2 Global Ivermectin in Veterinary Use Revenue by Region
3.2.1 Global Ivermectin in Veterinary Use Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Ivermectin in Veterinary Use Revenue by Region (2019-2024)
3.2.3 Global Ivermectin in Veterinary Use Revenue by Region (2025-2030)
3.2.4 Global Ivermectin in Veterinary Use Revenue 麻豆原创 Share by Region (2019-2030)
3.3 Global Ivermectin in Veterinary Use Sales Estimates and Forecasts 2019-2030
3.4 Global Ivermectin in Veterinary Use Sales by Region
3.4.1 Global Ivermectin in Veterinary Use Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Ivermectin in Veterinary Use Sales by Region (2019-2024)
3.4.3 Global Ivermectin in Veterinary Use Sales by Region (2025-2030)
3.4.4 Global Ivermectin in Veterinary Use Sales 麻豆原创 Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Ivermectin in Veterinary Use Sales by Manufacturers
4.1.1 Global Ivermectin in Veterinary Use Sales by Manufacturers (2019-2024)
4.1.2 Global Ivermectin in Veterinary Use Sales 麻豆原创 Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ivermectin in Veterinary Use in 2023
4.2 Global Ivermectin in Veterinary Use Revenue by Manufacturers
4.2.1 Global Ivermectin in Veterinary Use Revenue by Manufacturers (2019-2024)
4.2.2 Global Ivermectin in Veterinary Use Revenue 麻豆原创 Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Ivermectin in Veterinary Use Revenue in 2023
4.3 Global Ivermectin in Veterinary Use Sales Price by Manufacturers
4.4 Global Key Players of Ivermectin in Veterinary Use, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
4.5.2 Global Ivermectin in Veterinary Use 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Ivermectin in Veterinary Use, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Ivermectin in Veterinary Use, Product Offered and Application
4.8 Global Key Manufacturers of Ivermectin in Veterinary Use, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 麻豆原创 Size by Type
5.1 Global Ivermectin in Veterinary Use Sales by Type
5.1.1 Global Ivermectin in Veterinary Use Historical Sales by Type (2019-2024)
5.1.2 Global Ivermectin in Veterinary Use Forecasted Sales by Type (2025-2030)
5.1.3 Global Ivermectin in Veterinary Use Sales 麻豆原创 Share by Type (2019-2030)
5.2 Global Ivermectin in Veterinary Use Revenue by Type
5.2.1 Global Ivermectin in Veterinary Use Historical Revenue by Type (2019-2024)
5.2.2 Global Ivermectin in Veterinary Use Forecasted Revenue by Type (2025-2030)
5.2.3 Global Ivermectin in Veterinary Use Revenue 麻豆原创 Share by Type (2019-2030)
5.3 Global Ivermectin in Veterinary Use Price by Type
5.3.1 Global Ivermectin in Veterinary Use Price by Type (2019-2024)
5.3.2 Global Ivermectin in Veterinary Use Price Forecast by Type (2025-2030)
6 麻豆原创 Size by Application
6.1 Global Ivermectin in Veterinary Use Sales by Application
6.1.1 Global Ivermectin in Veterinary Use Historical Sales by Application (2019-2024)
6.1.2 Global Ivermectin in Veterinary Use Forecasted Sales by Application (2025-2030)
6.1.3 Global Ivermectin in Veterinary Use Sales 麻豆原创 Share by Application (2019-2030)
6.2 Global Ivermectin in Veterinary Use Revenue by Application
6.2.1 Global Ivermectin in Veterinary Use Historical Revenue by Application (2019-2024)
6.2.2 Global Ivermectin in Veterinary Use Forecasted Revenue by Application (2025-2030)
6.2.3 Global Ivermectin in Veterinary Use Revenue 麻豆原创 Share by Application (2019-2030)
6.3 Global Ivermectin in Veterinary Use Price by Application
6.3.1 Global Ivermectin in Veterinary Use Price by Application (2019-2024)
6.3.2 Global Ivermectin in Veterinary Use Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Ivermectin in Veterinary Use 麻豆原创 Size by Type
7.1.1 US & Canada Ivermectin in Veterinary Use Sales by Type (2019-2030)
7.1.2 US & Canada Ivermectin in Veterinary Use Revenue by Type (2019-2030)
7.2 US & Canada Ivermectin in Veterinary Use 麻豆原创 Size by Application
7.2.1 US & Canada Ivermectin in Veterinary Use Sales by Application (2019-2030)
7.2.2 US & Canada Ivermectin in Veterinary Use Revenue by Application (2019-2030)
7.3 US & Canada Ivermectin in Veterinary Use Sales by Country
7.3.1 US & Canada Ivermectin in Veterinary Use Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Ivermectin in Veterinary Use Sales by Country (2019-2030)
7.3.3 US & Canada Ivermectin in Veterinary Use Revenue by Country (2019-2030)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Ivermectin in Veterinary Use 麻豆原创 Size by Type
8.1.1 Europe Ivermectin in Veterinary Use Sales by Type (2019-2030)
8.1.2 Europe Ivermectin in Veterinary Use Revenue by Type (2019-2030)
8.2 Europe Ivermectin in Veterinary Use 麻豆原创 Size by Application
8.2.1 Europe Ivermectin in Veterinary Use Sales by Application (2019-2030)
8.2.2 Europe Ivermectin in Veterinary Use Revenue by Application (2019-2030)
8.3 Europe Ivermectin in Veterinary Use Sales by Country
8.3.1 Europe Ivermectin in Veterinary Use Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Ivermectin in Veterinary Use Sales by Country (2019-2030)
8.3.3 Europe Ivermectin in Veterinary Use Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Ivermectin in Veterinary Use 麻豆原创 Size by Type
9.1.1 China Ivermectin in Veterinary Use Sales by Type (2019-2030)
9.1.2 China Ivermectin in Veterinary Use Revenue by Type (2019-2030)
9.2 China Ivermectin in Veterinary Use 麻豆原创 Size by Application
9.2.1 China Ivermectin in Veterinary Use Sales by Application (2019-2030)
9.2.2 China Ivermectin in Veterinary Use Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Ivermectin in Veterinary Use 麻豆原创 Size by Type
10.1.1 Asia Ivermectin in Veterinary Use Sales by Type (2019-2030)
10.1.2 Asia Ivermectin in Veterinary Use Revenue by Type (2019-2030)
10.2 Asia Ivermectin in Veterinary Use 麻豆原创 Size by Application
10.2.1 Asia Ivermectin in Veterinary Use Sales by Application (2019-2030)
10.2.2 Asia Ivermectin in Veterinary Use Revenue by Application (2019-2030)
10.3 Asia Ivermectin in Veterinary Use Sales by Region
10.3.1 Asia Ivermectin in Veterinary Use Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Ivermectin in Veterinary Use Revenue by Region (2019-2030)
10.3.3 Asia Ivermectin in Veterinary Use Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Ivermectin in Veterinary Use 麻豆原创 Size by Type
11.1.1 Middle East, Africa and Latin America Ivermectin in Veterinary Use Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Ivermectin in Veterinary Use Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Ivermectin in Veterinary Use 麻豆原创 Size by Application
11.2.1 Middle East, Africa and Latin America Ivermectin in Veterinary Use Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Ivermectin in Veterinary Use Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Ivermectin in Veterinary Use Sales by Country
11.3.1 Middle East, Africa and Latin America Ivermectin in Veterinary Use Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Ivermectin in Veterinary Use Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Ivermectin in Veterinary Use Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Merck
12.1.1 Merck Company Information
12.1.2 Merck Overview
12.1.3 Merck Ivermectin in Veterinary Use Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Merck Ivermectin in Veterinary Use Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Merck Recent Developments
12.2 Bayview Pharmacy
12.2.1 Bayview Pharmacy Company Information
12.2.2 Bayview Pharmacy Overview
12.2.3 Bayview Pharmacy Ivermectin in Veterinary Use Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Bayview Pharmacy Ivermectin in Veterinary Use Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Bayview Pharmacy Recent Developments
12.3 Athens Life Sciences
12.3.1 Athens Life Sciences Company Information
12.3.2 Athens Life Sciences Overview
12.3.3 Athens Life Sciences Ivermectin in Veterinary Use Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Athens Life Sciences Ivermectin in Veterinary Use Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Athens Life Sciences Recent Developments
12.4 Geevet Remedies
12.4.1 Geevet Remedies Company Information
12.4.2 Geevet Remedies Overview
12.4.3 Geevet Remedies Ivermectin in Veterinary Use Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Geevet Remedies Ivermectin in Veterinary Use Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Geevet Remedies Recent Developments
12.5 Sriwalls Health Care
12.5.1 Sriwalls Health Care Company Information
12.5.2 Sriwalls Health Care Overview
12.5.3 Sriwalls Health Care Ivermectin in Veterinary Use Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Sriwalls Health Care Ivermectin in Veterinary Use Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Sriwalls Health Care Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Ivermectin in Veterinary Use Industry Chain Analysis
13.2 Ivermectin in Veterinary Use Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Ivermectin in Veterinary Use Production Mode & Process
13.4 Ivermectin in Veterinary Use Sales and 麻豆原创ing
13.4.1 Ivermectin in Veterinary Use Sales Channels
13.4.2 Ivermectin in Veterinary Use Distributors
13.5 Ivermectin in Veterinary Use Customers
14 Ivermectin in Veterinary Use 麻豆原创 Dynamics
14.1 Ivermectin in Veterinary Use Industry Trends
14.2 Ivermectin in Veterinary Use 麻豆原创 Drivers
14.3 Ivermectin in Veterinary Use 麻豆原创 Challenges
14.4 Ivermectin in Veterinary Use 麻豆原创 Restraints
15 Key Finding in The Global Ivermectin in Veterinary Use Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Merck
Bayview Pharmacy
Athens Life Sciences
Geevet Remedies
Sriwalls Health Care
听
听
*If Applicable.
